end stage renal failure - Nursing Case Study
Pathophysiology
• Primary mechanism: Loss of nephron function leads to reduced glomerular filtration rate (GFR), causing the accumulation of waste products like urea and creatinine in the blood, known as azotemia. This results in the symptoms of uremia, including nausea, fatigue, and confusion.
• Secondary mechanism: Impaired regulation of fluid, electrolytes, and acid-base balance. This can cause fluid overload, leading to hypertension and edema, and disturbances in electrolytes such as potassium and phosphate, potentially resulting in cardiac arrhythmias and bone disorders.
• Key complication: Reduced erythropoietin production by the kidneys leads to anemia, contributing to fatigue and decreased oxygen delivery to tissues, exacerbating patient symptoms and impacting overall quality of life.
Patient Profile
Demographics:
56-year-old female, retired school teacher
History:
• Key past medical history: Hypertension, type 2 diabetes diagnosed 10 years ago, chronic kidney disease for 5 years
• Current medications: Lisinopril, Metformin, Amlodipine, Epoetin alfa
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Fatigue and mild swelling in the ankles
• Key symptoms: Decreased urine output, loss of appetite, itching
• Vital signs: Blood pressure 135/85 mmHg, heart rate 78 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, oxygen saturation 98% on room air
Section 1
Initial Assessment Findings:
Upon further assessment, the nursing team notes that the patient's ankles exhibit mild pitting edema, rated at +1 on a 4-point scale, indicating fluid retention. The patient reports feeling more exhausted than usual, despite a full night's rest, and occasionally experiences shortness of breath during minimal exertion, such as climbing stairs. The patient's skin appears pale and dry, with visible scratch marks due to persistent itching, a common symptom associated with uremia. Despite these challenges, the patient remains alert and oriented, able to engage in conversation about her symptoms and daily life.
The nurse conducts a thorough physical examination, noting that the patient's heart sounds are regular with no murmurs, and lung sounds are clear bilaterally. However, the patient mentions occasional palpitations, prompting consideration of electrolyte imbalances, particularly potassium, which can affect cardiac function. The patient's blood pressure remains stable at 135/85 mmHg, suggesting good control of her hypertension with the current medication regimen. The nurse also measures the patient's weight, finding a slight increase from her baseline over the past week, consistent with fluid retention.
These findings prompt the care team to order a set of laboratory tests, including a complete blood count (CBC), serum electrolytes, blood urea nitrogen (BUN), creatinine, and a urinalysis, to evaluate the patient's renal function and electrolyte status further. The team aims to determine the underlying cause of her symptoms and adjust her treatment plan accordingly to improve her quality of life and manage her chronic condition effectively. This assessment lays the groundwork for revisiting her medication regimen and exploring potential interventions to address her anemia, fluid balance, and overall symptom management.
Section 2
New Diagnostic Results:
The laboratory results return, providing crucial insights into the patient's current health status. The complete blood count (CBC) reveals a hemoglobin level of 10 g/dL, indicating mild anemia, which could be contributing to her reported fatigue. The serum electrolytes show a potassium level of 5.2 mEq/L, slightly elevated but within a range that requires close monitoring to prevent potential cardiac complications. Her blood urea nitrogen (BUN) is elevated at 45 mg/dL, and creatinine is 2.5 mg/dL, both of which are consistent with her known chronic renal failure. The urinalysis reveals moderate proteinuria, a sign of ongoing kidney damage, but no signs of infection, as the leukocyte and nitrite tests are negative.
These findings confirm the presence of anemia and suggest that her current symptoms are likely exacerbated by her declining renal function. The care team discusses the importance of dietary modifications to manage her potassium levels and considers the potential addition of medications to stimulate erythropoiesis to address her anemia. Additionally, the team emphasizes the importance of fluid management to help reduce the mild edema and prevent further weight gain due to fluid retention.
With these results, the care team decides to schedule a follow-up appointment with a nephrologist to reassess her overall treatment plan and explore possible adjustments to her current medication regimen. They also plan to educate the patient about recognizing signs of worsening symptoms, such as increased shortness of breath or palpitations, which would warrant immediate medical attention. This proactive approach aims to enhance her quality of life and maintain stability in her condition, setting the stage for ongoing monitoring and intervention.
Section 3
Response to Interventions:
Following the initial assessment and implementation of the care team's recommendations, the patient returns for a follow-up appointment. The interventions aimed at managing her anemia and potassium levels appear to have been effective. Her most recent complete blood count shows a slight improvement in hemoglobin levels, now at 11 g/dL, suggesting a positive response to the erythropoiesis-stimulating agent prescribed. The potassium level has stabilized at 4.8 mEq/L, thanks to dietary modifications and the careful monitoring advised by her healthcare providers.
The patient reports feeling slightly less fatigued and notes a decrease in the mild edema previously observed in her lower extremities. Her current vital signs are stable: blood pressure is 130/85 mmHg, heart rate is 76 bpm, respiratory rate is 18 breaths per minute, and her temperature remains at 98.6°F (37°C). She has also been diligently following the fluid management plan, which has helped prevent further weight gain from fluid retention.
The care team is encouraged by these improvements but remains vigilant. They continue to stress the importance of adherence to dietary guidelines and medication schedules. They further educate the patient on recognizing early signs of complications, such as increased fatigue, muscle weakness, or irregular heartbeats, which could indicate issues with her potassium levels or anemia. With her next nephrology appointment scheduled, the team plans to reassess her medication regimen and her overall management plan, ensuring that her treatment continues to align with her evolving health status. This ongoing monitoring and patient education are crucial in maintaining her current stability and preventing future complications.
Section 4
In a subsequent follow-up appointment, the patient presents with some new concerns that indicate a change in her status. Although her previous reports showed stability, she now experiences increased fatigue and has noticed a slight return of edema in her ankles. During the clinical assessment, her vital signs remain generally stable, with a blood pressure of 128/84 mmHg and a heart rate of 78 bpm. However, her respiratory rate has slightly increased to 20 breaths per minute, which could suggest underlying fluid overload or other emerging issues.
Laboratory tests reveal a mild decrease in hemoglobin levels to 10.5 g/dL, indicating a potential need for adjustment in her erythropoiesis-stimulating agent dosage. Additionally, her potassium level has slightly risen to 5.1 mEq/L, which, while still within an acceptable range, requires close monitoring to prevent complications such as hyperkalemia. The care team notes these changes and emphasizes the importance of continued adherence to dietary restrictions, particularly regarding potassium-rich foods.
The healthcare team decides to adjust her anemia management plan, considering a possible increase in her medication dosage. They also reinforce the need for vigilance in monitoring her symptoms and stress the importance of promptly reporting any new or worsening signs, such as increased swelling or muscle weakness. The patient is scheduled for another follow-up in two weeks to closely monitor the effectiveness of these adjustments and to prevent any potential complications from arising. This proactive approach helps ensure that her treatment remains effective and aligned with her current health needs.
Section 5
Two weeks later, the patient returns for her follow-up appointment. She reports feeling slightly more energetic since the adjustment in her anemia management plan, yet she still experiences periods of fatigue that interfere with her daily activities. Her physical examination reveals that the edema in her ankles has not worsened but persists at a mild level. Her vital signs show a stable blood pressure of 126/82 mmHg and a heart rate of 76 bpm, with her respiratory rate having decreased slightly to 18 breaths per minute, suggesting some improvement in her fluid status.
The latest laboratory tests indicate that her hemoglobin level has increased to 11.2 g/dL, reflecting a positive response to the modified dosage of her erythropoiesis-stimulating agent. However, her potassium level remains at 5.1 mEq/L, necessitating continued dietary vigilance to prevent it from rising further. Her healthcare team reinforces dietary counseling, emphasizing the avoidance of high-potassium foods and the importance of maintaining adequate hydration without overconsumption, which could exacerbate edema.
While these findings show some stability, the care team remains cautious. They encourage the patient to continue monitoring her symptoms closely and to report any significant changes, such as increased swelling or muscle weakness. By maintaining open communication and adhering to her management plan, the patient can effectively navigate her condition. She is scheduled for another follow-up in one month to reassess her progress and make any necessary adjustments to her treatment regimen. This ongoing proactive approach is crucial in managing her early-stage end-stage renal failure and preventing further complications.